This summary explores the growing tide of evidence supporting the broad recognition that medication adherence is more than a barrier to successful clinical outcomes. Medication adherence may be the single most significant covariate limiting the successful analysis, evaluation and outcome of clinical trials.
Not so long ago, pharmaceutical brand managers considered drug packaging an afterthought. Today, packaging not only matters, it is quickly becoming one of the most important considerations in the growth and success of any drug product. Manufacturers now consider innovative, smart packaging that pleases patients in their new roles as consumers, and encourages brand loyalty to be a game changer in an increasingly competitive and crowded biopharmaceutical market.